Substance use: impact on adherence and HIV medical treatment (Q37920746)

25 August 2017

1 reference

title

Substance use: impact on adherence and HIV medical treatment (English)

1 reference

25 August 2017

0 references

0 references

Adam Gonzalez

1

1 reference

PubMed ID

21858414

25 August 2017

Jennifer Barinas

series ordinal

2

1 reference

PubMed ID

21858414

25 August 2017

Conall O'Cleirigh

series ordinal

3

1 reference

25 August 2017

1 December 2011

1 reference

25 August 2017

Current HIV/AIDS reports

1 reference

25 August 2017

8

1 reference

25 August 2017

4

1 reference

25 August 2017

223-234

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-011-0093-5

25 August 2017

0 references

cites work

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

The survival benefits of AIDS treatment in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Interrelation between psychiatric disorders and the prevention and treatment of HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Factors associated with HIV viral load in a respondent driven sample in Los Angeles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Associations between substance use, sexual risk taking and HIV treatment adherence among homeless people living with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Alcohol use and antiretroviral adherence: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Costs of care for people living with combined HIV/AIDS, chronic mental illness, and substance abuse disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Retention in care: a challenge to survival with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Emergency department utilization among HIV-infected patients in a multisite multistate study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Utilization of medical treatments and adherence to antiretroviral therapy among HIV-positive adults with histories of childhood sexual abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

The therapeutic implications of timely linkage and early retention in HIV care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Retention and attendance of women enrolled in a large prospective study of HIV-1 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Does self-report data on HIV primary care utilization agree with medical record data for socially marginalized populations in the United States?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): relevance for clinical management and intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Alcohol use accelerates HIV disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Causal considerations on alcohol and HIV/AIDS--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Alcohol consumption and lipodystrophy in HIV-infected adults with alcohol problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Screening for hazardous alcohol use and depressive symptomatology among HIV-infected patients in Nigeria: prevalence, predictors, and association with adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

The influence of different types of alcoholic beverages on disrupting highly active antiretroviral treatment (HAART) outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Brief report: Predictors of optimal HIV appointment adherence in minority youth: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Factors associated with poor adherence to anti-retroviral therapy in patients attending a rural health centre in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

"No one can ask me 'Why do you take that stuff?'": men's experiences of antiretroviral treatment in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Alcohol use and non-adherence to antiretroviral therapy in HIV-infected patients in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Risk-factors for non-adherence to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

HIV care providers' implementation of routine alcohol reduction support for their patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Systematic cultural adaptation of cognitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Self-reevaluation as a critical component in sustained viral load change for HIV+ adults with alcohol problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Medication assisted treatment in the treatment of drug abuse and dependence in HIV/AIDS infected drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Effects of nurse-delivered home visits combined with telephone calls on medication adherence and quality of life in HIV-infected heroin users in Hunan of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Drug use and medication adherence among HIV-1 infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Never in care: characteristics of HIV-infected crack cocaine users in 2 US cities who have never been to outpatient HIV care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Reductions in alcohol and cocaine use following a group coping intervention for HIV-positive adults with childhood sexual abuse histories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Outcomes from a group intervention for coping with HIV/AIDS and childhood sexual abuse: reductions in traumatic stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Cannabis use in HIV for pain and other medical symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Marijuana effectiveness as an HIV self-care strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

The methamphetamine epidemic: implications for HIV prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Smoking cessation in HIV patients: rate of success and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Cigarette smoking and HIV: more evidence for action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Review: the need for smoking cessation among HIV-positive smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Motivation and patch treatment for HIV+ smokers: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

A test of motivational plus nicotine replacement interventions for HIV positive smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Anxiety sensitivity as a moderator of association between smoking status and panic-related processes in a representative sample of adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Substance abuse treatment in an urban HIV clinic: who enrolls and what are the benefits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Directly observed therapy for the management of HIV-infected patients in a methadone program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

ACT HEALTHY: A Combined Cognitive-Behavioral Depression and Medication Adherence Treatment for HIV-Infected Substance Users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Effectiveness of the AUDIT-C as a screening test for alcohol misuse in three race/ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

AUDIT-C as a brief screen for alcohol misuse in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0093-5

Nonadherence among HIV-infected injecting drug users: the impact of social instability

21 January 2018

1 reference

12 December 2020

Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study.

1 reference

12 December 2020

HIV System Navigation: an emerging model to improve HIV care access

1 reference

12 December 2020

Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries

1 reference

12 December 2020

Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection

1 reference

12 December 2020

Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse

1 reference

12 December 2020

Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial

1 reference

12 December 2020

Non-adherence to anti-TB drugs among TB/HIV co-infected patients in Mbarara Hospital Uganda: prevalence and associated factors.

1 reference

12 December 2020

Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009.

1 reference

12 December 2020

Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Patterns of substance use among a large urban cohort of HIV-infected men who have sex with men in primary care

1 reference

12 December 2020

The promise of outreach for engaging and retaining out-of-care persons in HIV medical care.

1 reference

12 December 2020

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

12 December 2020

Risk factors for HIV disease progression in a rural southwest American Indian population

1 reference

12 December 2020

Mood and substance use disorders in older adults with HIV/AIDS: methodological issues and preliminary evidence.

1 reference

12 December 2020

Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study

1 reference

12 December 2020

Adherence to triple therapy and viral load response

1 reference

12 December 2020

10.1007/S11904-011-0093-5

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21858414